Frontlight ResearchEarly access
Trial site
Clinical Advancement Center
- 9running trials
- 3closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Obesity6 trials
- Type 2 diabetes6 trials
- Chronic kidney disease5 trials
- Heart failure2 trials
- Nephrotic syndrome2 trials
- Coronary artery disease1 trial
- High blood pressure1 trial
- IgA nephropathy1 trial
- Peripheral artery disease1 trial
- Stroke1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 37 trials
- Phase 25 trials
- Status
- Active, not recruiting3 trials
- Completed3 trials
- Not yet recruiting3 trials
- Recruiting3 trials
- Lead sponsor
- Novo Nordisk A/S7 trials
- Eli Lilly and Company2 trials
- Regeneron Pharmaceuticals1 trial
- Travere Therapeutics, Inc.1 trial
- Walden Biosciences1 trial
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Recruiting
Recruiting
Study of WAL0921 in Patients With Glomerular Kidney Diseases
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity3 recruiting
- Type 2 diabetes3 recruiting
- Chronic kidney disease1 recruiting
- High blood pressure1 recruiting
- IgA nephropathy1 recruiting
- Nephrotic syndrome1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026